BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12509490)

  • 1. Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise-trained mice.
    Danson EJ; Paterson DJ
    J Physiol; 2003 Jan; 546(Pt 1):225-32. PubMed ID: 12509490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice.
    Choate JK; Danson EJ; Morris JF; Paterson DJ
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2310-7. PubMed ID: 11709397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria.
    Herring N; Golding S; Paterson DJ
    J Mol Cell Cardiol; 2000 Oct; 32(10):1795-804. PubMed ID: 11013124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of neuronal nitric oxide synthase into intracardiac Ganglia reverses vagal impairment in hypertensive rats.
    Heaton DA; Li D; Almond SC; Dawson TA; Wang L; Channon KM; Paterson DJ
    Hypertension; 2007 Feb; 49(2):380-8. PubMed ID: 17210833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in the isolated guinea-pig atria.
    Choate JK; Paterson DJ
    J Auton Nerv Syst; 1999 Feb; 75(2-3):100-8. PubMed ID: 10189110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro.
    Herring N; Paterson DJ
    J Physiol; 2001 Sep; 535(Pt 2):507-18. PubMed ID: 11533140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired regulation of neuronal nitric oxide synthase and heart rate during exercise in mice lacking one nNOS allele.
    Danson EJ; Mankia KS; Golding S; Dawson T; Everatt L; Cai S; Channon KM; Paterson DJ
    J Physiol; 2004 Aug; 558(Pt 3):963-74. PubMed ID: 15155789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphonylurea-sensitive channels and NO-cGMP pathway modulate the heart rate response to vagal nerve stimulation in vitro.
    Almond SC; Paterson DJ
    J Mol Cell Cardiol; 2000 Nov; 32(11):2065-73. PubMed ID: 11040109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation.
    Sears CE; Choate JK; Paterson DJ
    J Appl Physiol (1985); 1999 Feb; 86(2):510-6. PubMed ID: 9931184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitric oxide synthase inhibition on the sympatho-vagal contol of heart rate.
    Sears CE; Choate JK; Paterson DJ
    J Auton Nerv Syst; 1998 Aug; 73(1):63-73. PubMed ID: 9808372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function.
    Mohan RM; Heaton DA; Danson EJ; Krishnan SP; Cai S; Channon KM; Paterson DJ
    Circ Res; 2002 Dec; 91(12):1089-91. PubMed ID: 12480808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac enkephalins attenuate vagal bradycardia: interactions with NOS-1-cGMP systems in canine sinoatrial node.
    Farias M; Jackson K; Johnson M; Caffrey JL
    Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2001-12. PubMed ID: 12881216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NO-cGMP pathway increases the hyperpolarisation-activated current, I(f), and heart rate during adrenergic stimulation.
    Herring N; Rigg L; Terrar DA; Paterson DJ
    Cardiovasc Res; 2001 Dec; 52(3):446-53. PubMed ID: 11738061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide: a modulator, but not a mediator, of neurovascular coupling in rat somatosensory cortex.
    Lindauer U; Megow D; Matsuda H; Dirnagl U
    Am J Physiol; 1999 Aug; 277(2):H799-811. PubMed ID: 10444508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nitric oxide synthase and nitric oxide-sensitive guanylate cyclase in the crustacean cardiac ganglion.
    Scholz NL; Labenia JS; de Vente J; Graubard K; Goy MF
    J Comp Neurol; 2002 Dec; 454(2):158-67. PubMed ID: 12412140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats.
    Li D; Wang L; Lee CW; Dawson TA; Paterson DJ
    Hypertension; 2007 Jul; 50(1):69-74. PubMed ID: 17515453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide inhibits arginine-vasotocin-induced increase of water osmotic permeability in frog urinary bladder.
    Fock EM; Lavrova EA; Bachteeva VT; Chernigovskaya EV; Parnova RG
    Pflugers Arch; 2004 May; 448(2):197-203. PubMed ID: 14722776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells.
    Schwarz PM; Rodriguez-Pascual F; Koesling D; Torres M; Förstermann U
    Neuroscience; 1998 Jan; 82(1):255-65. PubMed ID: 9483518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed.
    Ralevic V
    Br J Pharmacol; 2002 Sep; 137(1):19-28. PubMed ID: 12183327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation.
    Sears CE; Choate JK; Paterson DJ
    J Appl Physiol (1985); 1998 May; 84(5):1596-603. PubMed ID: 9572804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.